Articles dans des revues avec comité de lecture (100)
  1. 25. Krayem, M., Aftimos, P., Najem, A., van den Hooven, T., van den Berg, A., Hovestad-Bijl, L., de Wijn, R., Hilhorst, R., Ruijtenbeek, R., Sabbah, M., Kerger, J., Awada, A., Journé, F., & Ghanem, G. E. (2020). Erratum: Krayem, M., et al. Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title. Cancers (Basel), 12(10), 2981, 1-2. doi:10.3390/cancers12102981
  2. 26. Descamps, G., Verset, L., Trelcat, A., Hopkins, C., Lechien, J., Journé, F., & Saussez, S. (2020). Ace2 protein landscape in the head and neck region: The conundrum of SARS-CoV-2 infection. Biology, 9(8), 235, 1-14. doi:10.3390/biology9080235
  3. 27. Soumoy, L., Wells, M., Najem, A., Krayem, M., Ghanem, G. E., Hambÿe, S., Saussez, S., Blankert, B., & Journé, F. (2020). Toad venom antiproliferative activities on metastatic melanoma: Bio-guided fractionation and screening of the compounds of two different venoms. Biology, 9(8), 218, 1-16. doi:10.3390/biology9080218
  4. 28. Lechien, J., Ducarme, M., Place, S., Chiesa-Estomba, C. M., Khalife, M., De Riu, G., Vaira, L., de Terwangne, C., Machayekhi, S., Marchant, A., Journé, F., & Saussez, S. (2020). Objective olfactory findings in hospitalized severe COVID-19 patients. Pathogens, 9(8), 627, 1-6. doi:10.3390/pathogens9080627
  5. 29. Absil, L., Journé, F., Larsimont, D., Body, J.-J., Tafforeau, L., & Nonclercq, D. (2020). Farnesoid X receptor as marker of osteotropism of breast cancers through its role in the osteomimetism of tumor cells. BMC cancer, 20(1), 07106. doi:10.1186/s12885-020-07106-7
  6. 30. Soumoy, L., Schepkens, C., Krayem, M., Najem, A., Tagliatti, V., Ghanem, G. E., Saussez, S., Colet, J.-M., & Journé, F. (2020). Metabolic reprogramming in metastatic melanoma with acquired resistance to targeted therapies: Integrative metabolomic and proteomic analysis. Cancers (Basel), 12(5), 1323. doi:10.3390/cancers12051323
  7. 31. Lechien, J., Descamps, G., Seminerio, I., Furgiuele, S., Dequanter, D., Mouawad, F., Badoual, C., Journé, F., & Saussez, S. (2020). HPV involvement in the tumor microenvironment and immune treatment in head and neck squamous cell carcinomas. Cancers (Basel), 12(5), 1060. doi:10.3390/cancers12051060
  8. 32. Lechien, J., Chiesa-Estomba, C. M., De Siati, D. D., Horoi, M., Le Bon, S.-D., Rodriguez, A., Dequanter, D., Blecic, S., El Afia, F., Distinguin, L., Chekkoury-Idrissi, Y., Hans, S., Delgado, I. L., Calvo-Henriquez, C., Lavigne, P., Falanga, C., Barillari, M. R., Cammaroto, G., Khalifé, M., Leich, P., Souchay, C., Rossi, C., Journé, F., Hsieh, J. J., Edjlali, M., Carlier, R. Y., Ris, L., Lovato, A., De Filippis, C., Coppee, F., Fakhry, N., Ayad, T., & Saussez, S. (2020). Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European archives of oto-rhino-laryngology. doi:10.1007/s00405-020-05965-1
  9. 33. Krayem, M., Aftimos, P., Najem, A., van den Hooven, T., van den Berg, A., Hovestad-Bijl, L., de Wijn, R., Hilhorst, R., Ruijtenbeek, R., Sabbah, M., Kerger, J., Awada, A., Journé, F., & Ghanem, G. E. (2020). Kinome Profiling to Predict Sensitivity to MAPK Inhibition in Melanoma and to Provide New Insights into Intrinsic and Acquired Mechanism of Resistance Short Title: Sensitivity Prediction to MAPK Inhibitors in Melanoma. Cancers (Basel), 12(2). doi:10.3390/cancers12020512
  10. 34. Lardinois, I., Dequanter, D., Lechien, J., Bouland, C., Javadian, R., Rodriguez, A., Loeb, I., Journé, F., & Saussez, S. (2020). Survival and treatment outcome of head and neck cancer patients with pulmonary oligometastases. Clinical otolaryngology. doi:10.1111/coa.13668
  11. 35. Lechien, J., Seminerio, I., Descamps, G., Mat, Q., Mouawad, F., Hans, S., Julieron, M., Dequanter, D., Vanderhaegen, T., Journé, F., & Saussez, S. (2019). Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review. Cells, 8(9). doi:10.3390/cells8091061
  12. 36. Krayem, M., Sabbah, M., Najem, A., Wouters, A., Lardon, F., Simon, S., Sales, F., Journé, F., Awada, A., Ghanem, G. E., & Van Gestel, D. (2019). The benefit of reactivating p53 under MAPK inhibition on the efficacy of radiotherapy in melanoma. Cancers (Basel), 11(8), 1093. doi:10.3390/cancers11081093
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 Suivant >>